OpenFilings
PharmaCyte Biotech, Inc.
Form
8-K
Report Period
2023-07-14
Date Filed
2023-07-19
Time Filed
19:05:03
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
AMENDMENT NO. 6 TO THE BYLAWS OF PHARMACYTE BIOTECH, INC.
Filing on SEC Edgar